CCC publication: Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer

Citation: Pancreas. 2020, 49(10), 1410

Author: Ghaneh P.; Palmer D.; Halloran C.M.; Cicconi S.; Jackson R.; Rawcliffe C.; Sripadam R.; Mukherjee S.; Wadsley J.; Al-Muktar A.; Jiao L.; Wassan H.; Carter R.; Graham J.; Evans J.; Ahmed F.; Tjaden C.; Hackert T.; Buchler M.W.; Neoptolemos J.P.